BioCentury | Mar 4, 2020
Finance
March 3 Quick Takes: Megarounds for Akouos, Element; plus venture rounds by Kahr, Primmune, Lipidio and Scipio and more
...of TLR7 that are designed to activate systemic innate immunity. Lipidio raising series A round Lipidio Pharmaceuticals Inc....
...Signal regulatory protein α Paul Bonanos, Associate Editor, and Hongjiang Li, Staff Writer Akouos Inc. Element Science Inc. Lipidio Pharmaceuticals Inc. Scipio...
...Signal regulatory protein α Paul Bonanos, Associate Editor, and Hongjiang Li, Staff Writer Akouos Inc. Element Science Inc. Lipidio Pharmaceuticals Inc. Scipio...
